TY - JOUR
T1 - Use of biofilm model systems to study antimicrobial susceptibility.
AU - Pratten, Jonathan
AU - Ready, Derren
N1 - Copyright:
This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
PY - 2010
Y1 - 2010
N2 - There are many laboratory biofilm models available which can be used to assess the susceptibility of these distinctive resistant phenotypes. The complexities of these models vary considerably and indeed, the antimicrobial susceptibility of biofilms grown in these different models are also not standardised. It is clear that such methods are necessary for the testing of antibiotics and antimicrobial agents since these persistent communities are far more resistant than their planktonic counterparts. Therefore, it is now apparent that standardised tests such as MIC are no longer appropriate on their own to fully characterise susceptibility. There has also been a growing realisation that bacteria are growing as biofilms in almost every health-care setting and are, thus, a major contributing factor to the difficulty of treating infections. There is a pressing need for the models outlined in this chapter to test both current and novel anti-biofilm compounds and materials.
AB - There are many laboratory biofilm models available which can be used to assess the susceptibility of these distinctive resistant phenotypes. The complexities of these models vary considerably and indeed, the antimicrobial susceptibility of biofilms grown in these different models are also not standardised. It is clear that such methods are necessary for the testing of antibiotics and antimicrobial agents since these persistent communities are far more resistant than their planktonic counterparts. Therefore, it is now apparent that standardised tests such as MIC are no longer appropriate on their own to fully characterise susceptibility. There has also been a growing realisation that bacteria are growing as biofilms in almost every health-care setting and are, thus, a major contributing factor to the difficulty of treating infections. There is a pressing need for the models outlined in this chapter to test both current and novel anti-biofilm compounds and materials.
UR - http://www.scopus.com/inward/record.url?scp=77954666495&partnerID=8YFLogxK
U2 - 10.1007/978-1-60327-279-7_16
DO - 10.1007/978-1-60327-279-7_16
M3 - Article
C2 - 20401597
AN - SCOPUS:77954666495
SN - 1064-3745
VL - 642
SP - 203
EP - 215
JO - Methods in molecular biology (Clifton, N.J.)
JF - Methods in molecular biology (Clifton, N.J.)
ER -